Li et al discovered that MAOA was downregulated in cholangiocarcinoma (ICC) specimens through hypermethylation orinterleukin‐6 (IL‐6) signaling and that MAOA could serve as a prognostic biomarker for ICC patients.30 The gene discussed is MAOA; the disease is intrahepatic cholangiocarcinoma.